Dannielle Appelhans leads manufacturing, technical development, supply chain, engineering and operations strategy for all clinical and commercial assets at Novartis Gene Therapies.

Since joining Novartis in 2014, Dannielle has held roles within Novartis and Sandoz Biopharmaceuticals, serving most recently as Novartis’ Global Head of Supply Chain, where she was responsible for the global end-to-end supply chain for all Novartis divisions. Prior to joining Novartis, she held leadership positions in pharmaceutical manufacturing at Eli Lilly & Company and consulting at McKinsey & Company.

Dannielle holds a Bachelor of Science in Mechanical Engineering from the University of Michigan, as well as a Master of Business Administration and a Master of Mechanical Engineering from the Massachusetts Institute of Technology.